MedTrace Logo

Ciprofol Based on Total Intravenous Anesthesia During Pediatric Laparoscopic Surgery

NCT06735430 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2025-12-29

No results posted yet for this study

Summary

a prospective, double-blind, fully randomized controlled, non-inferiority clinical trial to investigate the use of total intravenous anesthesia in pediatric laparoscopic surgery.

Conditions

  • Pediatric Hernia
  • Laparoscopic Surgery
  • Appendicitis, Surgery

Interventions

DRUG

Ciprofol

Ciprofol for anesthesia induction (0.5mg / kg) and anesthesia maintenance (1-2.5mg/ (kg·h))

DRUG

Propofol

Propofol for anesthesia induction (2mg / kg) and maintenance of anesthesia (4-10 mg / (kg·h))

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • mujun Chang, Dr. · Tongji Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-09
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06735430 on ClinicalTrials.gov